DNA Damage Response in Glioblastoma Mechanism for Treatment Resistance and Emerging Therapeutic Strategies

被引：9

作者：

Bonm, Alipi ^{[1
]}

Kesari, Santosh ^{[2
,3
]}

机构：

[1] Univ Washington, Dept Neurol, Seattle, WA 98195 USA

[2] Pacific Neurosci Inst, Santa Monica, CA USA

[3] St Johns Canc Inst, Santa Monica, CA USA

来源：

CANCER JOURNAL | 2021年 / 27卷 / 05期

关键词：

DNA damage response; double-strand break; glioblastoma; PARP; single-strand break; GROWTH-FACTOR RECEPTOR; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; TUMOR-CELLS; PHASE-III; KINASE; INHIBITOR; REPAIR; TEMOZOLOMIDE; EXPRESSION;

D O I：

10.1097/PPO.0000000000000540

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glioblastoma (GBM) is an intrinsically treatment-resistant tumor and has been shown to upregulate DNA damage response (DDR) components after treatment. DNA damage response signaling mediates treatment resistance by promoting cell cycle arrest in order to allow for DNA damage repair and avoid mitotic catastrophe. Therefore, targeting the DDR pathway is an attractive strategy to combat treatment resistance in GBM. In this review, we discuss the different DDR pathways and then summarize the current preclinical evidence for DDR inhibitors in GBM, as well as completed and ongoing clinical trials.

引用

收藏

页码：379 / 385

页数：7

相关论文

共 50 条

[31] The emerging role of Polycomb repressors in the response to DNA damage [J].

Vissers, Joseph H. A. ;

van Lohuizen, Maarten ;

Citterio, Elisabetta .

JOURNAL OF CELL SCIENCE, 2012, 125 (17) :3939-3948

[32] The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme [J].

Bambury, Richard M. ;

Morris, Patrick G. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (08) :955-964

[33] Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer [J].

Cossar, L. H. ;

Schache, A. G. ;

Risk, J. M. ;

Sacco, J. J. ;

Jones, N. J. ;

Lord, R. .

CLINICAL ONCOLOGY, 2017, 29 (09) :626-634

[34] Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide [J].

Sato, Yuichi ;

Kurose, Akira ;

Ogawa, Akira ;

Ogasawara, Kuniaki ;

Traganos, Frank ;

Darzynkiewicz, Zbigniew ;

Sawai, Takashi .

CANCER BIOLOGY & THERAPY, 2009, 8 (05) :452-457

[35] DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets [J].

Mathew Lozinski ;

Nikola A. Bowden ;

Moira C. Graves ;

Michael Fay ;

Paul A. Tooney .

Cellular Oncology, 2021, 44 :961-981

[36] The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response [J].

Yuan, Sheng ;

Zuo, Wei ;

Liu, Tingting ;

Fu, Huan .

TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22

[37] DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies [J].

Mirza-Aghazadeh-Attari, Mohammad ;

Ostadian, Caspian ;

Saei, Amir Ata ;

Mihanfar, Ainaz ;

Darband, Saber Ghazizadeh ;

Sadighparvar, Shirin ;

Kaviani, Mojtaba ;

Kafil, Hossein Samadi ;

Yousefi, Bahman ;

Majidinia, Maryam .

DNA REPAIR, 2019, 80 :59-84

[38] DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies [J].

Kwok, Marwan ;

Agathanggelou, Angelo ;

Stankovic, Tatjana .

BLOOD, 2024, 143 (21) :2123-2144

[39] The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment [J].

Annovazzi, Laura ;

Caldera, Valentina ;

Mellai, Marta ;

Riganti, Chiara ;

Battaglia, Luigi ;

Chirio, Daniela ;

Melcarne, Antonio ;

Schiffer, Davide .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (06) :2299-2308

[40] DNA damage response and repair in the development and treatment of brain tumors [J].

Dana, Parisa Maleki ;

Sadoughi, Fatemeh ;

Mirzaei, Hamed ;

Asemi, Zatollah ;

Yousefi, Bahman .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 924

← 1 2 3 4 5 →